Jordan's Hikma, Affected By 'Arab Spring,' To Resume Libya Sales
This article was originally published in PharmAsia News
Executive Summary
Jordan's Hikma Pharmaceuticals said it plans to resume marketing its drugs in Libya by the end of the year, ending a hiatus brought about by political upheaval